Breakthrough Study: UAB Researchers Determine Optimal Immunosuppression Regimen for Pig-to-Human Kidney Transplants

Currently used Food and Drug Administration-approved transplant drugs — with the addition of an also already FDA-approved complement inhibitor — are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark di

Related Keywords

United States ,American ,Jim Parsons ,Andrew Shunk ,Julie Houp ,Maggie Jones Carr ,Jackson Perry ,Jody Potterwith ,Jayme Locke ,Paige Porrett ,Leigh Mcmanus ,Douglas Anderson ,Anupam Agarwal ,Gavin Baker ,Vineeta Kumar ,Division Of Transplantation ,Marnixe Heersink School Of Medicine ,Heersink School Of Medicine ,Department Of Anesthesiology ,Department Of Surgery ,Department Of Pathology ,Division Of Nephrology ,Department Of Medicine ,Heersink School Of Medicine Dean ,Division Of Infectious Diseases ,Revivicor Inc ,United Therapeutics Corporation ,University Of Alabama At Birmingham ,Drug Administration Approved ,American Journal ,United Therapeutics ,Medicine Dean ,Senior Vice President ,Medicine Anupam Agarwal ,Infectious Diseases ,Perioperative Medicine ,Heersink School ,Huma Fatima ,Lung Biotechnology ,